Phase 2, Randomized, Double-Blind, Dose-Ranging Study Evaluating the Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Complicated Skin and Skin Structure Infections

Emergence of Multidrug-Resistant, Community-Associated, Methicillin-Resistant Staphylococcus aureus Clone USA300 in Men Who Have Sex with Men

(2013) Binh An Diep et al.   ANNALS OF INTERNAL MEDICINE

In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial Agent

(2009) R. Schaadt et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

New Semiphysiological Absorption Model To Assess the Pharmacodynamic Profile of Cefuroxime Axetil Using Nonparametric and Parametric Population Pharmacokinetics

(2009) J. B. Bulitta et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Methicillin‐ResistantStaphylococcus aureus–Associated Hospitalizations among the American Indian and Alaska Native Population

(2009) Kathy K. Byrd et al.   CLINICAL INFECTIOUS DISEASES

Dissemination of Methicillin‐ResistantStaphylococcus aureusUSA300 Sequence Type 8 Lineage in Latin America

(2009) Jinnethe Reyes et al.   CLINICAL INFECTIOUS DISEASES

Short-course therapy for bloodstream infections in immunocompetent adults

(2009) G. Ralph Corey et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Heterogeneous Vancomycin‐Intermediate Susceptibility Phenotype in Bloodstream Methicillin‐ResistantStaphylococcus aureusIsolates from an International Cohort of Patients with Infective Endocarditis: Prevalence, Genotype, and Clinical Significance

(2009) In‐Gyu Bae et al.   JOURNAL OF INFECTIOUS DISEASES

Vancomycin Heteroresistance and Methicillin-ResistantStaphylococcus aureus

(2009) Stan Deresinski   JOURNAL OF INFECTIOUS DISEASES

Telavancin

(2009) G. Ralph Corey et al.   NATURE REVIEWS DRUG DISCOVERY

Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin

(2008) T. P. Lodise et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains

(2008) K. J. Shaw et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Skin and Soft‐Tissue Infections Caused by Community‐Acquired Methicillin‐ResistantStaphylococcus aureus

(2008) Martin E. Stryjewski et al.   CLINICAL INFECTIOUS DISEASES

Global Implications of the Emergence of Community‐Associated Methicillin‐ResistantStaphylococcus aureusin Indigenous Populations

(2008) Steven Y. C. Tong et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology of Methicillin‐ResistantStaphylococcus aureus

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

The Graying of Methicillin-Resistant Staphylococcus aureus

(2008) Kyle J. Popovich et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY